CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement

en

Ways to trade

Experienced retail trader

Trading platforms

Trading info

Fraud prevention

Trading tools

Our markets

Cryptocurrencies

Market updates

Market analysis

Pricing

Charges and fees

Our business model

For trading beginners

Trading essentials

Risk-management

For experienced traders

Trading Strategies

Technical analysis

Market analysis

Trading Psychology

About us

Why Capital.com?

Leadership team

Tech recruitment

Get help

Client vulnerability

Terms and policies

Compliance & Legals

Complaints Procedure (CCSV)

en

Home Markets SharesHOOKIPA Pharma Inc.

Trade HOOKIPA Pharma Inc. - HOOK CFD

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company''s lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.

Latest shares articles

Lloyds share price forecast: An attractive dividend stock?

Lloyds forecast: will Lloyds share price return to £1? Third party data forecast

What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?

13:36, 8 July 2024

Exterior of Infosys headquarters

Infosys shareholders: Who owns the most INFY stock?

Who are the major shareholders and decision-makers of Infosys?

07:12, 29 April 2024

Tesla shareholders: Who owns the most TSLA stock?

In this guide to Tesla’s ownership structure, we look at the biggest TSLA shareholders – both institutional and individual

08:00, 19 April 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

14:43, 2 February 2024

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.

Very trustworthy and affordable for any size trades

It is very easy to connect with TradingView but the web interface is also great.

Easy to use and great support. Been using it for 2 years already and still happy

Capital.com is one of the best stock trading platforms I’ve used. The UX and UI on both the mobile app and web platform are outstanding, making it incredibly easy to navigate. They’ve built a vibrant community of traders and investors, and their UAE team really stands out for delivering an exceptional trading experience.

Best broker!! they call you to see if you need any help. The app is good and nice better than the rest

Great app! I requested some features to be added, such as analysis tools, and they delivered. Amazing job! The agents are always helpful and reply quickly. It’s not 5 stars because, at times, some less experienced agents may say it’s impossible to fulfill the request or fix the problem while another agent, like Angel, quickly escalated the issue to the necessary team/person/department and resolved it

This is an excellent platform. The stop loss and take profit work very well; however, when the changes are very fast like at the beginning of the session, the stop loss does not work. If this defect is corrected it will be the perfect platform.

-Nice -Easy to use - Beautiful Interface

I think I'm new in this trading platform, but I find it affordable and most reliable. To be honest I'm not fully experienced trader, but with very limited knowledge of trading I try learn as much as I can by trying out different platforms see if can make money. My interests growing in you platform, l like news updates you also short videos on YouTube, other propaganda, poster and many more. I will see what happens in the coming months. Thanks capital team.

Gives you options to start learning how too do it as it gives you a demo option to learn from your mistakes

Efficiency. When creating the account, it was smooth, efficient from start to finish. Verification of documents also was done the same day, unlike other platforms where you have to wait a day or two.

From what I'm seeing it's cool Mixing it with trading view it's perfect... I didn't give it 5 star yet cos I still need to use it for some time

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

4.6

Ratings and Reviews

4.7

Ratings and Reviews

4.4

4.3

Ready to join a leading broker?

Join our community of traders worldwide

1. Create your account2. Make your first deposit3. Start trading